These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 11551881)

  • 1. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
    Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
    Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.
    Ichinose F; Bloch KD; Wu JC; Hataishi R; Aretz HT; Picard MH; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1070-5. PubMed ID: 14644766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.
    Sam F; Sawyer DB; Xie Z; Chang DL; Ngoy S; Brenner DA; Siwik DA; Singh K; Apstein CS; Colucci WS
    Circ Res; 2001 Aug; 89(4):351-6. PubMed ID: 11509452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarction.
    Gorressen S; Stern M; van de Sandt AM; Cortese-Krott MM; Ohlig J; Rassaf T; Gödecke A; Fischer JW; Heusch G; Merx MW; Kelm M
    PLoS One; 2015; 10(4):e0120961. PubMed ID: 25875863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
    Liu YH; Carretero OA; Cingolani OH; Liao TD; Sun Y; Xu J; Li LY; Pagano PJ; Yang JJ; Yang XP
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2616-23. PubMed ID: 16055518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice.
    Feng Q; Lu X; Jones DL; Shen J; Arnold JM
    Circulation; 2001 Aug; 104(6):700-4. PubMed ID: 11489778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
    Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
    Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular remodeling in a mouse model of myocardial infarction.
    Patten RD; Aronovitz MJ; Deras-Mejia L; Pandian NG; Hanak GG; Smith JJ; Mendelsohn ME; Konstam MA
    Am J Physiol; 1998 May; 274(5):H1812-20. PubMed ID: 9612394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Reduction in Myocyte Autophagy After Myocardial Infarction in Rabbits: Association with Oxidative Stress and Left Ventricular Remodeling.
    Chi RF; Wang JP; Wang K; Zhang XL; Zhang YA; Kang YM; Han XB; Li B; Qin FZ; Fan BA
    Cell Physiol Biochem; 2017; 44(6):2439-2454. PubMed ID: 29268264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Suematsu N; Kinugawa S; Ide T; Wen J; Takeshita A
    Circulation; 2002 Feb; 105(7):868-73. PubMed ID: 11854129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
    Wang S; Fei K; Xu YW; Wang LX; Chen YQ
    Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction.
    Bauersachs J; Galuppo P; Fraccarollo D; Christ M; Ertl G
    Circulation; 2001 Aug; 104(9):982-5. PubMed ID: 11524389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-lipid diet potentiates left ventricular dysfunction in nitric oxide synthase 3-deficient mice after chronic pressure overload.
    Ahmadie R; Santiago JJ; Walker J; Fang T; Le K; Zhao Z; Azordegan N; Bage S; Lytwyn M; Rattan S; Dixon IM; Kardami E; Moghadasian MH; Jassal DS
    J Nutr; 2010 Aug; 140(8):1438-44. PubMed ID: 20554900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.